DrugDashboards

Market view

idelalisib · Tablet, Film Coated

4 marketed package NDCs · 2 active manufacturers

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

Same drug class

Other molecules FDA puts in Kinase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Idelalisib in shortage right now?
No. FDA does not currently list Idelalisib in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Idelalisib?
4 companies have marketed Idelalisib in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • Planned discontinuationZydelig, Tablet, 100 mg (NDC 61958-1701-1)Apr 7, 2026
  • Planned discontinuationZydelig, Tablet, 150 mg (NDC 61958-1702-1)Apr 7, 2026

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.